Article

Pharmaceutical Technology's In the Lab eNewsletter

In the Lab eNewsletter

Pharmaceutical Technology's In the Lab eNewsletter-05-06-2020
Volume15
Issue 5
Pages: 28-29

Centogene to Open New Lab for COVID-19 Testing

The lab is expected to open in April 2020 and will increase the company’s capacity for diagnostic testing of rare genetic diseases along with its COVID-19 capabilities.

Centogene, a Germany-based commercial-stage company focused on rare diseases, announced on April 15, 2020 that it will open a new laboratory in Hamburg, Germany to increase testing capacity for COVID-19.

The lab facilities and equipment were acquired from Provecs Medical, a company formerly active in cancer immunotherapy, a company press release said. The lab is expected to open in April 2020 and will increase the company’s capacity for diagnostic testing of rare genetic diseases along with its COVID-19 capabilities.

"The opening of our lab in Hamburg will significantly contribute to the scaling and success of our COVID-19 testing initiative,” said Dr. Arndt Rolfs, CEO, Centogene, in the press release. “Once we have overcome the challenges of this pandemic and returned to a sense of normalcy, we will further equip our labs in order to continue to strengthen our commitment to rare disease patients around the world ─ offering transformational medical solutions."

Source: Centogene

 

 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More